Abstract

THIS STUDY investigates the injection of sterilized xenogeneic placental protein extract before challenge with viable Ehrlich tumor cells for enhancement of the immune system. It includes the estimation of tumor size, hematological study and determination of CD8, granzyme B enzyme and caspase-3 activities, MMP-(2&9) activities and protein fractionation in serum.Female mice are divided into: G1 is the control group. G2 is the Ehrlich treated group, injected with 2.5×105 viable tumor cells/mouse. G3 is vaccinated with xenogeneic placental extract (XPE) sterilized using 0.2 micron Millipore filters. G4 is vaccinated with XPE sterilized with gamma irradiation at dose level of 2 Gy. G3 and G4 are subdivided into a, b, c and d.Results demonstrated that subgroups 3a, 3c, 3d, 4a, 4b, 4c and 4d showed significant decrease in mean tumor size compared to G2. For lymphocyte count, subgroups 3d, 4b, 4c and 4d revealed a significant increase compared to G1. Subgroup 4d showed a significant increase in both CD8 and granzyme B activities compared to G1. The caspase-3 activity indicated significantly in subgroups 4c and 4d compared to G1. Serum MMP-(2&9) activities revealed that the 4d subgroup displays the less pronounced band compared to the other groups and to G2. Gel electrophoresis showed that Ehrlich protein and placental protein extract were represented by four bands detected at 7kDa, between 29kDa and 45kDa, at >67kDa and at >116kDa.It could be concluded that vaccination using xenogeneic placental extract targets the stimulation of the immune system.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.